We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
151
Lowe's Companies
LOW
$119B
$1.55M 0.19%
+5,732
New +$1.39M
RRR icon
152
Red Rock Resorts
RRR
$3.8B
$1.55M 0.19%
+28,493
New +$1.59M
DLB icon
153
Dolby
DLB
$4.85B
$1.55M 0.19%
+20,258
New +$1.51M
MMS icon
154
Maximus
MMS
$3.2B
$1.53M 0.18%
16,470
-10,768
-40% -$962K
CI icon
155
Cigna
CI
$77B
$1.53M 0.18%
4,418
-1,819
-29% -$626K
CAH icon
156
Cardinal Health
CAH
$53.7B
$1.52M 0.18%
13,723
+10,301
+301% +$1.08M
DAR icon
157
Darling Ingredients
DAR
$9.62B
$1.51M 0.18%
40,691
-35,369
-47% -$1.33M
RGA icon
158
Reinsurance Group of America
RGA
$15.7B
$1.51M 0.18%
6,927
+1,056
+18% +$225K
XOM icon
159
ExxonMobil
XOM
$642B
$1.51M 0.18%
+12,864
New +$1.49M
RACE icon
160
Ferrari
RACE
$66.8B
$1.5M 0.18%
+3,192
New +$1.43M
MRUS
161
DELISTED
Merus
MRUS
$1.5M 0.18%
+30,003
New +$1.57M
AMG icon
162
Affiliated Managers Group
AMG
$9.61B
$1.5M 0.18%
8,416
+3,364
+67% +$571K
MEDP icon
163
Medpace
MEDP
$16.5B
$1.49M 0.18%
+4,478
New +$1.7M
PGNY icon
164
Progyny
PGNY
$2.47B
$1.49M 0.18%
+88,622
New +$2.13M
MTN icon
165
Vail Resorts
MTN
$5.28B
$1.48M 0.18%
+8,520
New +$1.52M
PYPL icon
166
PayPal
PYPL
$49.5B
$1.48M 0.18%
19,008
+4,154
+28% +$278K
EXPE icon
167
Expedia Group
EXPE
$33.4B
$1.48M 0.18%
10,011
+6,814
+213% +$903K
GOOGL icon
168
Alphabet (Google) Class A
GOOGL
$3.99T
$1.47M 0.18%
8,876
+2,708
+44% +$454K
WING icon
169
Wingstop
WING
$3.74B
$1.46M 0.17%
+3,505
New +$1.36M
DELL icon
170
Dell
DELL
$276B
$1.46M 0.17%
+12,292
New +$1.43M
CSTM icon
171
Constellium
CSTM
$4.02B
$1.45M 0.17%
89,197
+48,324
+118% +$820K
MPWR icon
172
Monolithic Power Systems
MPWR
$65.8B
$1.45M 0.17%
+1,568
New +$1.35M
MSCI icon
173
MSCI
MSCI
$41.5B
$1.45M 0.17%
2,483
+1,739
+234% +$943K
RGLD icon
174
Royal Gold
RGLD
$17.1B
$1.44M 0.17%
10,279
+4,130
+67% +$565K
ESI icon
175
Element Solutions
ESI
$9.22B
$1.44M 0.17%
52,994
+30,664
+137% +$803K
5 6
7
8 9

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.